• Aucun résultat trouvé

Pathogenesis and diagnosis of delayed-type drug hypersensitivity reactions, from bedside to bench and back

N/A
N/A
Protected

Academic year: 2021

Partager "Pathogenesis and diagnosis of delayed-type drug hypersensitivity reactions, from bedside to bench and back"

Copied!
11
0
0

Texte intégral

Loading

Figure

Table adapted from [2].
Fig. 2  Abacavir-induced altered self-peptide presentation (adopted from Ostrov et al
Table 2  Well-defined HLA associations in DHR [28]

Références

Documents relatifs

We believe that our diagnosis is justified because the patient did not have abnormal results on liver function tests before initiation of tocilizumab therapy; her new morbilliform

This paper investigates parametric maximum likelihood estimation of the time-to-onset distribution of adverse drug reactions from spontaneous reporting data for dif- ferent types

GNILC uses smoothing to suppress the CIBA within the regions of the total intensity maps at each scale within the spherical wavelet domain where the nuisance contributions

À la formation générale des jeunes (préscolaire, primaire et secondaire), le Conseil soulignait deux zones de vulnérabilité au regard de l’accès à l’éducation et à la

Controversies exist with regard to in vivo approaches to delayed immunologically mediated adverse drug reactions, such as exanthem (maculopapular eruption), drug reaction

Health care professionals must be aware of the potential for serious adverse reac- tions, including neuropathy, when linezolid is used beyond its

A summary of health professional and consumer advisories posted between February 10, 2004, and May 17, 2004, is available in this issue of the Canadian Adverse

A search of the Health Canada adverse reaction database revealed four reports in which sterol and sterolin-containing products were suspected of being associated with